Approval · Notice of Compliance 17111 · 2015
ERIVEDGE: Notice of Compliance 17111
Issued July 17, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17111
- Date
- July 17, 2015
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Efficacy and safety update to the product monograph based on lenger term follow up of patients on the pivotal trial
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERIVEDGE | Not yet assigned | — |
Medicinal ingredients
- VISMODEGIB 150 MG per CAP